Three months ended | |||||||||||||||||||||||||||||
(in millions, except per-share data) | 6/30/2024 | 6/30/2023 | Change(1) | 3/31/2024 | Change(1) | ||||||||||||||||||||||||
U.S. GAAP basis | |||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,585.6 | $ | 1,430.8 | 10.8 | % | $ | 1,554.0 | 2.0 | % | |||||||||||||||||||
Capital allocation-based income(2) | $ | 0.1 | $ | 38.7 | n/m | $ | 47.1 | n/m | |||||||||||||||||||||
Net revenues | $ | 1,733.3 | $ | 1,610.2 | 7.6 | % | $ | 1,750.2 | (1.0) | % | |||||||||||||||||||
Operating expenses | $ | 1,168.6 | $ | 1,076.7 | 8.5 | % | $ | 1,163.6 | 0.4 | % | |||||||||||||||||||
Net operating income | $ | 564.7 | $ | 533.5 | 5.8 | % | $ | 586.6 | (3.7) | % | |||||||||||||||||||
Non-operating income (loss) | $ | 80.3 | $ | 106.2 | n/m | $ | 188.9 | n/m | |||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 483.4 | $ | 476.4 | 1.5 | % | $ | 573.8 | (15.8) | % | |||||||||||||||||||
Diluted earnings per common share | $ | 2.11 | $ | 2.06 | 2.4 | % | $ | 2.49 | (15.3) | % | |||||||||||||||||||
Weighted average common shares outstanding assuming dilution | 223.5 | 225.2 | (0.8) | % | 224.2 | (0.3) | % | ||||||||||||||||||||||
Adjusted basis(3) | |||||||||||||||||||||||||||||
Operating expenses | $ | 1,105.8 | $ | 1,026.2 | 7.8 | % | $ | 1,071.4 | 3.2 | % | |||||||||||||||||||
Operating expenses, excluding accrued carried interest related compensation | $ | 1,097.3 | $ | 1,010.5 | 8.6 | % | $ | 1,052.9 | 4.2 | % | |||||||||||||||||||
Net operating income | $ | 654.9 | $ | 596.6 | 9.8 | % | $ | 692.4 | (5.4) | % | |||||||||||||||||||
Non-operating income (loss) | $ | 34.7 | $ | 31.8 | 9.1 | % | $ | 28.5 | n/m | ||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 519.7 | $ | 466.5 | 11.4 | % | $ | 548.5 | (5.3) | % | |||||||||||||||||||
Diluted earnings per common share | $ | 2.26 | $ | 2.02 | 11.9 | % | $ | 2.38 | (5.0) | % | |||||||||||||||||||
Assets under management (in billions) | |||||||||||||||||||||||||||||
Average assets under management | $ | 1,534.0 | $ | 1,357.4 | 13.0 | % | $ | 1,484.4 | 3.3 | % | |||||||||||||||||||
Ending assets under management | $ | 1,569.1 | $ | 1,399.4 | 12.1 | % | $ | 1,542.2 | 1.7 | % | |||||||||||||||||||
Investment advisory annualized effective fee rate in basis points (bps) | 41.6 | 42.3 | (0.7) | 42.1 | (0.5) |
Three months ended 6/30/2024 | |||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 802.9 | $ | 170.9 | $ | 520.6 | $ | 47.8 | $ | 1,542.2 | |||||||||||||||||||
Net cash flows prior to manager-driven distributions | (14.9) | 7.8 | 1.6 | 2.9 | (2.6) | ||||||||||||||||||||||||
Manager-driven distributions | — | — | — | (1.1) | (1.1) | ||||||||||||||||||||||||
Net cash flows | (14.9) | 7.8 | 1.6 | 1.8 | (3.7) | ||||||||||||||||||||||||
Net market appreciation (depreciation) and income(3) | 22.3 | 1.2 | 6.9 | 0.2 | 30.6 | ||||||||||||||||||||||||
Change during the period | 7.4 | 9.0 | 8.5 | 2.0 | 26.9 | ||||||||||||||||||||||||
Assets under management at June 30, 2024 | $ | 810.3 | $ | 179.9 | $ | 529.1 | $ | 49.8 | $ | 1,569.1 |
Three months ended | |||||||||||||||||||||||||||||
(in millions) | 6/30/2024 | 6/30/2023 | Change | 3/31/2024 | Change | ||||||||||||||||||||||||
Investment advisory fees | |||||||||||||||||||||||||||||
Equity | $ | 948.9 | $ | 862.3 | 10.0 | % | $ | 949.6 | (0.1) | % | |||||||||||||||||||
Fixed income, including money market | 100.2 | 100.0 | 0.2 | % | 100.6 | (0.4) | % | ||||||||||||||||||||||
Multi-asset | 444.8 | 391.3 | 13.7 | % | 429.7 | 3.5 | % | ||||||||||||||||||||||
Alternatives | 91.7 | 77.2 | 18.8 | % | 74.1 | 23.8 | % | ||||||||||||||||||||||
Total investment advisory fees | 1,585.6 | 1,430.8 | 10.8 | % | 1,554.0 | 2.0 | % | ||||||||||||||||||||||
Capital allocation-based income(1) | 0.1 | 38.7 | n/m | 47.1 | n/m | ||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 147.6 | 140.7 | 4.9 | % | 149.1 | (1.0) | % | ||||||||||||||||||||||
Net revenues | $ | 1,733.3 | $ | 1,610.2 | 7.6 | % | $ | 1,750.2 | (1.0) | % | |||||||||||||||||||
Average AUM (in billions): | |||||||||||||||||||||||||||||
Equity | $ | 790.4 | $ | 703.4 | 12.4 | % | $ | 770.4 | 2.6 | % | |||||||||||||||||||
Fixed income, including money market | 174.8 | 170.4 | 2.6 | % | 169.5 | 3.1 | % | ||||||||||||||||||||||
Multi-asset | 520.1 | 439.0 | 18.5 | % | 497.0 | 4.6 | % | ||||||||||||||||||||||
Alternatives | 48.7 | 44.6 | 9.2 | % | 47.5 | 2.5 | % | ||||||||||||||||||||||
Average AUM | $ | 1,534.0 | $ | 1,357.4 | 13.0 | % | $ | 1,484.4 | 3.3 | % | |||||||||||||||||||
Investment advisory annualized effective fee rate (bps) | 41.6 | 42.3 | (0.7) | 42.1 | (0.5) | ||||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||||||||
(in millions) | 6/30/2024 | 6/30/2023 | Change (1) | 3/31/2024 | Change (1) | ||||||||||||||||||||||||
Compensation, benefits, and related costs | $ | 635.8 | $ | 591.0 | 7.6 | % | $ | 629.3 | 1.0 | % | |||||||||||||||||||
Acquisition-related retention agreements | 13.1 | 13.6 | (3.7) | % | 13.5 | (3.0) | % | ||||||||||||||||||||||
Capital allocation-based income compensation(2) | (2.4) | 10.6 | n/m | 13.2 | n/m | ||||||||||||||||||||||||
Supplemental savings plan | 14.6 | 33.0 | n/m | 53.0 | n/m | ||||||||||||||||||||||||
Total compensation and related costs | 661.1 | 648.2 | 2.0 | % | 709.0 | (6.8) | % | ||||||||||||||||||||||
Distribution and servicing | 87.7 | 67.8 | 29.4 | % | 81.9 | 7.1 | % | ||||||||||||||||||||||
Advertising and promotion | 33.3 | 22.9 | 45.4 | % | 25.3 | 31.6 | % | ||||||||||||||||||||||
Product and recordkeeping related costs | 73.0 | 77.7 | (6.0) | % | 75.0 | (2.7) | % | ||||||||||||||||||||||
Technology, occupancy, and facility costs | 160.9 | 154.7 | 4.0 | % | 149.9 | 7.3 | % | ||||||||||||||||||||||
General, administrative, and other | 108.7 | 100.0 | 8.7 | % | 92.6 | 17.4 | % | ||||||||||||||||||||||
Change in fair value of contingent consideration | — | (23.2) | n/m | — | n/m | ||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 43.9 | 28.6 | 53.5 | % | 29.9 | 46.8 | % | ||||||||||||||||||||||
Total operating expenses | $ | 1,168.6 | $ | 1,076.7 | 8.5 | % | $ | 1,163.6 | 0.4 | % | |||||||||||||||||||
Total adjusted operating expenses(3) | $ | 1,105.8 | $ | 1,026.2 | 7.8 | % | $ | 1,071.4 | 3.2 | % | |||||||||||||||||||
(in millions) | Three months ended | ||||||||||||||||
6/30/2024 | 6/30/2023 | 3/31/2024 | |||||||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||||||||
Cash and discretionary investments | |||||||||||||||||
Dividend income | $ | 33.6 | $ | 25.5 | $ | 27.8 | |||||||||||
Market-related gains (losses) and equity in earnings (losses) | 0.1 | 6.3 | 0.2 | ||||||||||||||
Total net gains (losses) from cash and discretionary investments | 33.7 | 31.8 | 28.0 | ||||||||||||||
Seed capital investments | |||||||||||||||||
Dividend income | 0.3 | 0.4 | — | ||||||||||||||
Market-related gains (losses) and equity in earnings (losses) | 15.3 | 14.4 | 23.5 | ||||||||||||||
Investments used to hedge the supplemental savings plan liability | 14.8 | 33.6 | 49.7 | ||||||||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 64.1 | 80.2 | 101.2 | ||||||||||||||
Other investment income (loss) | 13.9 | 8.9 | 20.3 | ||||||||||||||
Net gains (losses) on investments | 78.0 | 89.1 | 121.5 | ||||||||||||||
Net gains (losses) on consolidated sponsored investment products | 8.5 | 24.4 | 72.3 | ||||||||||||||
Other gains (losses), including foreign currency gains (losses) | (6.2) | (7.3) | (4.9) | ||||||||||||||
Non-operating income (loss) | $ | 80.3 | $ | 106.2 | $ | 188.9 | |||||||||||
Six months ended | |||||||||||
6/30/2024 | 6/30/2023 | ||||||||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | |||||||
State income taxes for current year, net of federal income tax benefits(1) | 2.7 | 2.9 | |||||||||
Net (income) losses attributable to redeemable non-controlling interests(2) | (0.4) | (0.3) | |||||||||
Net excess tax losses (benefits) from stock-based compensation plans activity | (0.3) | (0.3) | |||||||||
Valuation allowances | 0.5 | 3.6 | |||||||||
Other items | 0.6 | (0.2) | |||||||||
Effective income tax rate | 24.1 | % | 26.7 | % | |||||||
Public Relations | Investor Relations | ||||||||||
Jamaal Mobley | Linsley Carruth | ||||||||||
410-345-3403 | 410-345-3717 | ||||||||||
jamaal.mobley@troweprice.com | linsley.carruth@troweprice.com | ||||||||||
Unaudited Consolidated Statements of Income | |||||||||||||||||||||||||||||||||||
(in millions, except per-share amounts) | |||||||||||||||||||||||||||||||||||
Three months ended | Six months ended | ||||||||||||||||||||||||||||||||||
Revenues | 6/30/2024 | 6/30/2023 | 3/31/2024 | 6/30/2024 | 6/30/2023 | ||||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,585.6 | $ | 1,430.8 | $ | 1,554.0 | $ | 3,139.6 | $ | 2,822.6 | |||||||||||||||||||||||||
Capital allocation-based income | 0.1 | 38.7 | 47.1 | 47.2 | 55.6 | ||||||||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 147.6 | 140.7 | 149.1 | 296.7 | 269.6 | ||||||||||||||||||||||||||||||
Net revenues | 1,733.3 | 1,610.2 | 1,750.2 | 3,483.5 | 3,147.8 | ||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||
Compensation, benefits, and related costs | 635.8 | 591.0 | 629.3 | 1,265.1 | 1,184.3 | ||||||||||||||||||||||||||||||
Acquisition-related retention agreements | 13.1 | 13.6 | 13.5 | 26.6 | 27.8 | ||||||||||||||||||||||||||||||
Capital allocation-based income compensation | (2.4) | 10.6 | 13.2 | 10.8 | 14.1 | ||||||||||||||||||||||||||||||
Supplemental savings plan | 14.6 | 33.0 | 53.0 | 67.6 | 75.5 | ||||||||||||||||||||||||||||||
Total compensation and related costs | 661.1 | 648.2 | 709.0 | 1,370.1 | 1,301.7 | ||||||||||||||||||||||||||||||
Distribution and servicing | 87.7 | 67.8 | 81.9 | 169.6 | 139.3 | ||||||||||||||||||||||||||||||
Advertising and promotion | 33.3 | 22.9 | 25.3 | 58.6 | 48.7 | ||||||||||||||||||||||||||||||
Product and recordkeeping related costs | 73.0 | 77.7 | 75.0 | 148.0 | 149.8 | ||||||||||||||||||||||||||||||
Technology, occupancy, and facility costs | 160.9 | 154.7 | 149.9 | 310.8 | 301.3 | ||||||||||||||||||||||||||||||
General, administrative, and other | 108.7 | 100.0 | 92.6 | 201.3 | 207.5 | ||||||||||||||||||||||||||||||
Change in fair value of contingent consideration | — | (23.2) | — | — | (72.8) | ||||||||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 43.9 | 28.6 | 29.9 | 73.8 | 54.6 | ||||||||||||||||||||||||||||||
Total operating expenses | 1,168.6 | 1,076.7 | 1,163.6 | 2,332.2 | 2,130.1 | ||||||||||||||||||||||||||||||
Net operating income | 564.7 | 533.5 | 586.6 | 1,151.3 | 1,017.7 | ||||||||||||||||||||||||||||||
Non-operating income (loss) | |||||||||||||||||||||||||||||||||||
Net gains (losses) on investments | 78.0 | 89.1 | 121.5 | 199.5 | 183.0 | ||||||||||||||||||||||||||||||
Net gains (losses) on consolidated sponsored investment products | 8.5 | 24.4 | 72.3 | 80.8 | 69.8 | ||||||||||||||||||||||||||||||
Other gains (losses), including foreign currency gains (losses) | (6.2) | (7.3) | (4.9) | (11.1) | (11.2) | ||||||||||||||||||||||||||||||
Total non-operating income (loss) | 80.3 | 106.2 | 188.9 | 269.2 | 241.6 | ||||||||||||||||||||||||||||||
Income before income taxes | 645.0 | 639.7 | 775.5 | 1,420.5 | 1,259.3 | ||||||||||||||||||||||||||||||
Provision for income taxes | 159.7 | 158.5 | 182.1 | 341.8 | 336.4 | ||||||||||||||||||||||||||||||
Net income | 485.3 | 481.2 | 593.4 | 1,078.7 | 922.9 | ||||||||||||||||||||||||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | 1.9 | 4.8 | 19.6 | 21.5 | 25.0 | ||||||||||||||||||||||||||||||
Net income attributable to T. Rowe Price | 483.4 | 476.4 | 573.8 | 1,057.2 | 897.9 | ||||||||||||||||||||||||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 12.9 | 11.6 | 15.8 | 28.7 | 22.1 | ||||||||||||||||||||||||||||||
Net income allocated to T. Rowe Price common stockholders | $ | 470.5 | $ | 464.8 | $ | 558.0 | $ | 1,028.5 | $ | 875.8 | |||||||||||||||||||||||||
Earnings per share | |||||||||||||||||||||||||||||||||||
Basic | $ | 2.11 | $ | 2.07 | $ | 2.50 | $ | 4.61 | $ | 3.90 | |||||||||||||||||||||||||
Diluted | $ | 2.11 | $ | 2.06 | $ | 2.49 | $ | 4.60 | $ | 3.89 | |||||||||||||||||||||||||
Weighted-average common shares | |||||||||||||||||||||||||||||||||||
Outstanding | 223.0 | 224.4 | 223.6 | 223.3 | 224.4 | ||||||||||||||||||||||||||||||
Outstanding assuming dilution | 223.5 | 225.2 | 224.2 | 223.8 | 225.2 | ||||||||||||||||||||||||||||||
Summary of Adjusted Basis(1) | Three months ended | Six months ended | |||||||||||||||||||||||||||||||||
(in millions, except per-share data) | 6/30/2024 | 6/30/2023 | 3/31/2024 | 6/30/2024 | 6/30/2023 | ||||||||||||||||||||||||||||||
Operating expenses | $ | 1,105.8 | $ | 1,026.2 | $ | 1,071.4 | $ | 2,177.2 | $ | 2,048.7 | |||||||||||||||||||||||||
Operating expenses, excluding accrued carried interest related compensation | $ | 1,097.3 | $ | 1,010.5 | $ | 1,052.9 | $ | 2,150.2 | $ | 2,024.4 | |||||||||||||||||||||||||
Net operating income | $ | 654.9 | $ | 596.6 | $ | 692.4 | $ | 1,347.3 | $ | 1,124.6 | |||||||||||||||||||||||||
Non-operating income (loss) | $ | 34.7 | $ | 31.8 | $ | 28.5 | $ | 63.2 | $ | 62.6 | |||||||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 519.7 | $ | 466.5 | $ | 548.5 | $ | 1,068.2 | $ | 855.9 | |||||||||||||||||||||||||
Diluted earnings per common share | $ | 2.26 | $ | 2.02 | $ | 2.38 | $ | 4.64 | $ | 3.71 | |||||||||||||||||||||||||
(1) See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release. |
Assets Under Management | Six months ended 6/30/2024 | ||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 743.6 | $ | 170.0 | $ | 483.0 | $ | 47.9 | $ | 1,444.5 | |||||||||||||||||||
Net cash flows prior to manager-driven distributions | (27.7) | 8.0 | 7.1 | 3.0 | (9.6) | ||||||||||||||||||||||||
Manager-driven distributions | — | — | — | (2.1) | (2.1) | ||||||||||||||||||||||||
Net cash flows(3) | (27.7) | 8.0 | 7.1 | 0.9 | (11.7) | ||||||||||||||||||||||||
Net market appreciation and gains(4) | 94.4 | 1.9 | 39.0 | 1.0 | 136.3 | ||||||||||||||||||||||||
Change during the period | 66.7 | 9.9 | 46.1 | 1.9 | 124.6 | ||||||||||||||||||||||||
Assets under management at June 30, 2024 | $ | 810.3 | $ | 179.9 | $ | 529.1 | $ | 49.8 | $ | 1,569.1 |
Net Revenues | Six months ended | ||||||||||||||||
(in millions) | 6/30/2024 | 6/30/2023 | % Change | ||||||||||||||
Investment advisory fees | |||||||||||||||||
Equity | $ | 1,898.5 | $ | 1,696.2 | 11.9 | % | |||||||||||
Fixed income, including money market | 200.8 | 202.4 | (0.8) | % | |||||||||||||
Multi-asset | 874.5 | 777.3 | 12.5 | % | |||||||||||||
Alternatives | 165.8 | 146.7 | 13.0 | % | |||||||||||||
Total investment advisory fees | $ | 3,139.6 | $ | 2,822.6 | 11.2 | % | |||||||||||
Average AUM (in billions): | |||||||||||||||||
Equity | $ | 780.4 | $ | 695.2 | 12.3 | % | |||||||||||
Fixed income, including money market | 172.1 | 170.0 | 1.2 | % | |||||||||||||
Multi-asset | 508.6 | 430.7 | 18.1 | % | |||||||||||||
Alternatives | 48.1 | 44.3 | 8.6 | % | |||||||||||||
Average AUM | $ | 1,509.2 | $ | 1,340.2 | 12.6 | % | |||||||||||
Non-Operating Income (Loss) | |||||||||||
(in millions) | Six months ended | ||||||||||
6/30/2024 | 6/30/2023 | ||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||
Cash and discretionary investments | |||||||||||
Dividend income | $ | 61.4 | $ | 45.7 | |||||||
Market-related gains (losses) and equity in earnings (losses) | 0.3 | 16.9 | |||||||||
Total net gains (losses) from cash and discretionary investments | 61.7 | 62.6 | |||||||||
Seed capital investments | |||||||||||
Dividend income | 0.3 | 0.9 | |||||||||
Market-related gains (losses) and equity in earnings (losses) | 38.8 | 29.5 | |||||||||
Investments used to hedge the supplemental savings plan liability | 64.5 | 78.3 | |||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 165.3 | 171.3 | |||||||||
Other investment income (loss) | 34.2 | 11.7 | |||||||||
Net gains (losses) on investments | 199.5 | 183.0 | |||||||||
Net gains (losses) on consolidated sponsored investment portfolios | 80.8 | 69.8 | |||||||||
Other gains (losses), including foreign currency gains (losses) | (11.1) | (11.2) | |||||||||
Non-operating income (loss) | $ | 269.2 | $ | 241.6 | |||||||
Six months ended | |||||||||||||||||||||||
6/30/2024 | |||||||||||||||||||||||
(in millions) | Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated T. Rowe Price investment products | Elims | As reported | |||||||||||||||||||
Cash flows from operating activities | |||||||||||||||||||||||
Net income (loss) | $ | 1,057.2 | $ | 75.9 | $ | (54.4) | $ | 1,078.7 | |||||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
Depreciation, amortization and impairments of property, equipment and software | 126.3 | — | — | 126.3 | |||||||||||||||||||
Amortization and impairment of acquisition-related assets and retention agreements | 124.1 | — | — | 124.1 | |||||||||||||||||||
Stock-based compensation expense | 112.6 | — | — | 112.6 | |||||||||||||||||||
Net (gains) losses recognized on investments | (267.8) | — | 54.4 | (213.4) | |||||||||||||||||||
Net redemptions in sponsored investment products used to economically hedge supplemental savings plan liability | 15.1 | — | — | 15.1 | |||||||||||||||||||
Net change in trading securities held by consolidated sponsored investment products | — | (218.0) | — | (218.0) | |||||||||||||||||||
Other changes | 302.9 | (1.5) | (11.8) | 289.6 | |||||||||||||||||||
Net cash provided by (used in) operating activities | 1,470.4 | (143.6) | (11.8) | 1,315.0 | |||||||||||||||||||
Net cash provided by (used in) investing activities | (75.7) | (13.1) | (4.6) | (93.4) | |||||||||||||||||||
Net cash provided by (used in) financing activities | (746.4) | 154.5 | 16.4 | (575.5) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products | — | (1.1) | — | (1.1) | |||||||||||||||||||
Net change in cash and cash equivalents during period | 648.3 | (3.3) | — | 645.0 | |||||||||||||||||||
Cash and cash equivalents at beginning of year | 2,066.6 | 77.2 | — | 2,143.8 | |||||||||||||||||||
Cash and cash equivalents at end of period | $ | 2,714.9 | $ | 73.9 | $ | — | $ | 2,788.8 |
Unaudited Condensed Consolidated Balance Sheet Information (in millions) | As of | ||||||||||
6/30/2024 | 12/31/2023 | ||||||||||
Cash and cash equivalents | $ | 2,714.9 | $ | 2,066.6 | |||||||
Accounts receivable and accrued revenue | 846.9 | 807.9 | |||||||||
Investments | 2,758.9 | 2,554.7 | |||||||||
Assets of consolidated sponsored investment products | 1,929.6 | 1,959.3 | |||||||||
Operating lease assets | 229.4 | 241.1 | |||||||||
Property, equipment and software, net | 884.5 | 806.6 | |||||||||
Goodwill and intangible assets | 3,085.1 | 3,150.1 | |||||||||
Other assets | 640.5 | 692.5 | |||||||||
Total assets | 13,089.8 | 12,278.8 | |||||||||
Supplemental savings plan liability | 941.7 | 895.0 | |||||||||
Total other liabilities, includes $65.1 at June 30, 2024, and $54.2 at December 31, 2023, from consolidated sponsored investment products | 1,325.1 | 1,092.6 | |||||||||
Non-controlling interests* | 894.3 | 786.1 | |||||||||
Stockholders' equity attributable to T. Rowe Price Group, Inc., 222.6 common shares outstanding at June 30, 2024 and 223.9 common shares outstanding at December 31, 2023 | $ | 9,928.7 | $ | 9,505.1 |
Three months ended | Six months ended | ||||||||||||||||||||||||||||
Investments in affiliated private investment funds - carried interest | 6/30/2024 | 6/30/2023 | 3/31/2024 | 6/30/2024 | 6/30/2023 | ||||||||||||||||||||||||
Balance at beginning of period | $ | 514.3 | $ | 483.8 | $ | 519.9 | $ | 519.9 | $ | 467.8 | |||||||||||||||||||
Capital allocation-based income: | |||||||||||||||||||||||||||||
Change in accrued carried interest | 27.0 | 51.0 | 59.5 | 86.5 | 80.2 | ||||||||||||||||||||||||
Acquisition-related amortization and impairments | (26.9) | (12.3) | (12.4) | (39.3) | (24.6) | ||||||||||||||||||||||||
Net distributions | (17.1) | (8.3) | (52.7) | (69.8) | (9.2) | ||||||||||||||||||||||||
Balance at end of period | $ | 497.3 | $ | 514.2 | $ | 514.3 | $ | 497.3 | $ | 514.2 |
Three months ended | Six months ended | ||||||||||||||||||||||||||||
Non-controlling interests (NCI) in consolidated entities | 6/30/2024 | 6/30/2023 | 3/31/2024 | 6/30/2024 | 6/30/2023 | ||||||||||||||||||||||||
Balance at beginning of period | $ | 205.4 | $ | 194.4 | $ | 192.0 | $ | 192.0 | $ | 190.7 | |||||||||||||||||||
Capital allocation-based income compensation: | |||||||||||||||||||||||||||||
Change in accrued carried interest compensation | 8.5 | 15.7 | 18.5 | 27.0 | 24.3 | ||||||||||||||||||||||||
Acquisition-related amortization and impairments | (10.9) | (5.1) | (5.3) | (16.2) | (10.2) | ||||||||||||||||||||||||
Net contributions (distributions) | 2.3 | (2.9) | 0.2 | 2.5 | (2.7) | ||||||||||||||||||||||||
Balance at end of period | $ | 205.3 | $ | 202.1 | $ | 205.4 | $ | 205.3 | $ | 202.1 |
Three months ended 6/30/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,168.6 | $ | 564.7 | $ | 80.3 | $ | 159.7 | $ | 483.4 | $ | 2.11 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 10.9 | 16.0 | — | 3.5 | 12.5 | 0.05 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.1) | 13.1 | — | 2.9 | 10.2 | 0.04 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (43.9) | 43.9 | — | 9.6 | 34.3 | 0.15 | |||||||||||||||||||||||||||||
Total acquisition-related | (46.1) | 73.0 | — | 16.0 | 57.0 | 0.24 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(2) (Compensation and related costs) | (14.6) | 14.6 | (14.8) | — | (0.2) | — | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(3) | (2.1) | 2.6 | (8.5) | (0.9) | (3.1) | (0.01) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (22.3) | (4.9) | (17.4) | (0.08) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,105.8 | $ | 654.9 | $ | 34.7 | $ | 169.9 | $ | 519.7 | $ | 2.26 |
Three months ended 6/30/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,076.7 | $ | 533.5 | $ | 106.2 | $ | 158.5 | $ | 476.4 | $ | 2.06 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.1 | 7.2 | — | 0.1 | 7.1 | 0.03 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.6) | 13.6 | — | (0.1) | 13.7 | 0.06 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 23.2 | (23.2) | — | 2.5 | (25.7) | (0.11) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (28.6) | 28.6 | — | 0.4 | 28.2 | 0.12 | |||||||||||||||||||||||||||||
Total acquisition-related | (13.9) | 26.2 | — | 2.9 | 23.3 | 0.10 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(2) (Compensation and related costs) | (33.0) | 33.0 | (33.6) | 0.2 | (0.8) | — | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(3) | (3.6) | 3.9 | (24.4) | 0.5 | (16.2) | (0.07) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (16.4) | (0.2) | (16.2) | (0.07) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,026.2 | $ | 596.6 | $ | 31.8 | $ | 161.9 | $ | 466.5 | $ | 2.02 |
Three months ended 3/31/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,163.6 | $ | 586.6 | $ | 188.9 | $ | 182.1 | $ | 573.8 | $ | 2.49 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.3 | 7.1 | — | 2.0 | 5.1 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.5) | 13.5 | — | 3.8 | 9.7 | 0.04 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (29.9) | 29.9 | — | 8.3 | 21.6 | 0.10 | |||||||||||||||||||||||||||||
Total acquisition-related | (38.1) | 50.5 | — | 14.1 | 36.4 | 0.16 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(2) (Compensation and related costs) | (53.0) | 53.0 | (49.7) | 0.9 | 2.4 | 0.01 | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(3) | (1.1) | 2.3 | (72.3) | (14.0) | (36.4) | (0.16) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (38.4) | (10.7) | (27.7) | (0.12) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,071.4 | $ | 692.4 | $ | 28.5 | $ | 172.4 | $ | 548.5 | $ | 2.38 |
Six months ended 6/30/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 2,332.2 | $ | 1,151.3 | $ | 269.2 | $ | 341.8 | $ | 1,057.2 | $ | 4.60 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 16.2 | 23.1 | — | 5.5 | 17.6 | 0.08 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (26.6) | 26.6 | — | 6.6 | 20.0 | 0.08 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (73.8) | 73.8 | — | 18.0 | 55.8 | 0.24 | |||||||||||||||||||||||||||||
Total acquisition-related | (84.2) | 123.5 | — | 30.1 | 93.4 | 0.40 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(2) (Compensation and related costs) | (67.6) | 67.6 | (64.5) | 0.8 | 2.3 | 0.01 | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(3) | (3.2) | 4.9 | (80.8) | (14.8) | (39.6) | (0.17) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (60.7) | (15.6) | (45.1) | (0.20) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 2,177.2 | $ | 1,347.3 | $ | 63.2 | $ | 342.3 | $ | 1,068.2 | $ | 4.64 |
Six months ended 6/30/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 2,130.1 | $ | 1,017.7 | $ | 241.6 | $ | 336.4 | $ | 897.9 | $ | 3.89 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 10.2 | 14.4 | — | 1.6 | 12.8 | 0.06 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (27.8) | 27.8 | — | 3.0 | 24.8 | 0.11 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 72.8 | (72.8) | — | (8.0) | (64.8) | (0.28) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (54.6) | 54.6 | — | 6.0 | 48.6 | 0.21 | |||||||||||||||||||||||||||||
Transaction costs(2) (General, admin and other) | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Total acquisition-related | 0.6 | 24.0 | — | 2.6 | 21.4 | 0.10 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(2) (Compensation and related costs) | (75.5) | 75.5 | (78.3) | (0.3) | (2.5) | (0.01) | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(3) | (6.5) | 7.4 | (69.8) | (4.1) | (33.3) | (0.14) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (30.9) | (3.3) | (27.6) | (0.13) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 2,048.7 | $ | 1,124.6 | $ | 62.6 | $ | 331.3 | $ | 855.9 | $ | 3.71 |
Three months ended | Six months ended | ||||||||||||||||||||||||||||
6/30/2024 | 6/30/2023 | 3/31/2024 | 6/30/2024 | 6/30/2023 | |||||||||||||||||||||||||
Adjusted net income attributable to T. Rowe Price | $ | 519.7 | $ | 466.5 | $ | 548.5 | $ | 1,068.2 | $ | 855.9 | |||||||||||||||||||
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 13.9 | 11.4 | 15.2 | 29.1 | 21.0 | ||||||||||||||||||||||||
Adjusted net income allocated to common stockholders | $ | 505.8 | $ | 455.1 | $ | 533.3 | $ | 1,039.1 | $ | 834.9 |